Market revenue in 2023 | USD 314.2 million |
Market revenue in 2030 | USD 598.6 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Hyaluronic acid |
Fastest growing segment | Hyaluronic acid |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Hyaluronic acid, Calcium hydroxylapatite, Polylactic acid (PLLA), Polymethyl-methacrylate microspheres |
Key market players worldwide | Galderma Group AG Registered Shares, Allergan, Revance Therapeutics Inc, Elevance Health Inc, Merz Pharma, Suneva Medical, Prollenium Medical Technologies, Teoxane Laboratories Geneva, Huadong Medicine, Marllor Biomedical, Sinclair Pharma plc, Medytox |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dermal fillers market will help companies and investors design strategic landscapes.
Hyaluronic acid was the largest segment with a revenue share of 81.13% in 2023. Horizon Databook has segmented the France dermal fillers market based on hyaluronic acid, calcium hydroxylapatite, polylactic acid (plla), polymethyl-methacrylate microspheres covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the France dermal fillers market , including forecasts for subscribers. This country databook contains high-level insights into France dermal fillers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account